The Prince Charles Hospital

Chermside 4032

2 studies enrolling now · 18 studies all time

What they study most

Acute Myocardial Infarction, Alzheimer Disease, Atherosclerotic Cardiovascular Disease, Atrial Arrhythmia, Atrial Fibrillation, Cystic Fibrosis, Interstitial Lung Disease, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Pulmonary Arterial Hypertension, Pulmonary Fibrosis, Scleroderma, Systemic

Studies at this site

• VOLT-AF IDE Clinical Study — Completed
• A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease — Running, not enrolling
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
• A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
• A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease — Stopped early
• A Study Evaluating the Long-term Safety of VX-445 Combination Therapy — Completed
• PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement — Completed
• A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis — Completed
• A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy — Stopped early
• A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed
• Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension — Completed
• Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis — Completed